Ser362
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
logos LINCs Logo Mt Sinai Logo NIH Logo NCI Logo
Phosphorylation Site Page:
Ser362 - Fos (mouse)

Site Information
AAAHRKGsSSNEPSS   SwissProt Entrez-Gene
Predicted information:  Scansite
Orthologous residues: Fos (human): S362, Fos (rat): S362
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448481

In vivo Characterization
Methods used to characterize site in vivo: immunoprecipitation (1), mutation of modification site (1, 3), phospho-antibody (1, 3), western blotting (1)
Relevant cell line - cell type - tissue: 3T3 (fibroblast) [SHP-2 (mouse), homozygous knockout] (3), bone (3), BV2 (microglia) (1), monocyte (3)

Controlled by
Putative upstream kinases: PKACA (mouse) (1), RSK2 (mouse) (3)
Treatments: LPS (1), M-CSF (3), MG132 (3)

Downstream Regulation
Effects of modification on Fos: molecular association, regulation (1), protein stabilization (3)
Induce interaction with: ER-beta (mouse) (1)


References

1

Saijo K, et al. (2011) An ADIOL-ERĪ²-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145, 584-95
21565615   Curated Info

2

Bakiri L, et al. (2011) Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis. Oncogene 30, 1506-17
21119595   Curated Info

3

David JP, et al. (2005) Essential role of RSK2 in c-Fos-dependent osteosarcoma development. J Clin Invest 115, 664-72
15719069   Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.